Hyperthermia European Adjuvant Trial

  • STATUS
    Recruiting
  • participants needed
    336
  • sponsor
    Klinikum der Universitaet Muenchen, Grosshadern
Updated on 20 August 2022

Summary

Improvement of the clinical outcome in patients with resectable pancreatic carcinoma through an intensified adjuvant treatment with gemcitabine, cisplatin and regional deep hyperthermia as compared to standard chemotherapy.

Details
Condition Resected Pancreatic Adenocarcinoma
Treatment Gemcitabine + Cisplatin + regional hyperthermia, Gemcitabine + Capecitabine
Clinical Study IdentifierNCT01077427
SponsorKlinikum der Universitaet Muenchen, Grosshadern
Last Modified on20 August 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note